← Back to Search

Exercise for Sedentary Lifestyle

N/A
Waitlist Available
Led By Eli Puterman, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up tracked weekly for 12 weeks
Awards & highlights

Study Summary

This trial will test if a 12-week mobile health aerobic exercise intervention can help reduce depression in healthcare workers.

Eligible Conditions
  • Sedentary Lifestyle
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~tracked biweekly for 12 weeks (baseline, followed by 12 weeks of exercise intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and tracked biweekly for 12 weeks (baseline, followed by 12 weeks of exercise intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in depressive symptomology over the course of the exercise intervention
Secondary outcome measures
Change in absenteeism over the course of the exercise intervention
Change in sleep quality over the course of the exercise intervention
Change in work-family spillover over the course of the exercise intervention
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise groupExperimental Treatment1 Intervention
Weeks 1 - 12: For the duration of the study, participant will be completing any of the physical activities customizable within the Down Dog apps. He/she will be asked to complete a minimum of four 20-minute workouts per week. Every two weeks, participant will receive a survey to complete. Week 24: At week 24 (12 weeks after their initial 12-week participation in the study), participant will receive a check-in email with the final survey to complete. Investigators will also record the use of the apps at week 24.
Group II: Waitlist control groupActive Control1 Intervention
Weeks 1 - 12: For the 12 weeks of the study, participant will be asked to continue their typical, pre-study daily and weekly routine, maintaining the physical activity he/she was completing before the start of the study. Every two weeks, the participant will receive a survey to complete. Week 24: • At the end of the first 12 weeks that he/she have access to the suite of apps (i.e., 24 weeks following their randomization to the waitlist control group), participant will receive a check-in email with the final survey to complete.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,673 Total Patients Enrolled
3 Trials studying Sedentary Lifestyle
177 Patients Enrolled for Sedentary Lifestyle
Providence Health & ServicesOTHER
117 Previous Clinical Trials
822,247 Total Patients Enrolled
Eli Puterman, PhDPrincipal InvestigatorThe University of British Columbia
2 Previous Clinical Trials
164 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still space available for participants to join this research endeavor?

"This clinical trial is not currently enrolling patients, as indicated on the clinicaltrials.gov website. Initially posted on March 31st 2022 and edited most recently in November 17th 2022, this particular study has been inactive for some time now; however, 1194 other trials are presently seeking participants to join their studies."

Answered by AI

Who else is applying?

What state do they live in?
British Columbia
How old are they?
18 - 65
What site did they apply to?
University of British Columbia
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~96 spots leftby Apr 2025